Parkinson's disease affects differently Met5- and Leu5-enkephalin in the human brain. 1983

H Taquet, and F Javoy-Agid, and M Hamon, and J C Legrand, and Y Agid, and F Cesselin

When measured in post-mortem human control brains, the ratio of Met5-enkephalin levels to those of Leu5-enkephalin varied from 1 to 13 in the 11 areas examined. In parkinsonian brains a significant reduction in the levels of both peptides was found in the pallidum and putamen whereas only Met5-enkephalin levels were decreased in the substantia nigra and ventral tegmental area. Therefore, Met5-enkephalin and Leu5-enkephalin may be located (at least partly) in different neuronal populations in the human brain.

UI MeSH Term Description Entries
D010300 Parkinson Disease A progressive, degenerative neurologic disease characterized by a TREMOR that is maximal at rest, retropulsion (i.e. a tendency to fall backwards), rigidity, stooped posture, slowness of voluntary movements, and a masklike facial expression. Pathologic features include loss of melanin containing neurons in the substantia nigra and other pigmented nuclei of the brainstem. LEWY BODIES are present in the substantia nigra and locus coeruleus but may also be found in a related condition (LEWY BODY DISEASE, DIFFUSE) characterized by dementia in combination with varying degrees of parkinsonism. (Adams et al., Principles of Neurology, 6th ed, p1059, pp1067-75) Idiopathic Parkinson Disease,Lewy Body Parkinson Disease,Paralysis Agitans,Primary Parkinsonism,Idiopathic Parkinson's Disease,Lewy Body Parkinson's Disease,Parkinson Disease, Idiopathic,Parkinson's Disease,Parkinson's Disease, Idiopathic,Parkinson's Disease, Lewy Body,Parkinsonism, Primary
D012016 Reference Values The range or frequency distribution of a measurement in a population (of organisms, organs or things) that has not been selected for the presence of disease or abnormality. Normal Range,Normal Values,Reference Ranges,Normal Ranges,Normal Value,Range, Normal,Range, Reference,Ranges, Normal,Ranges, Reference,Reference Range,Reference Value,Value, Normal,Value, Reference,Values, Normal,Values, Reference
D001921 Brain The part of CENTRAL NERVOUS SYSTEM that is contained within the skull (CRANIUM). Arising from the NEURAL TUBE, the embryonic brain is comprised of three major parts including PROSENCEPHALON (the forebrain); MESENCEPHALON (the midbrain); and RHOMBENCEPHALON (the hindbrain). The developed brain consists of CEREBRUM; CEREBELLUM; and other structures in the BRAIN STEM. Encephalon
D001923 Brain Chemistry Changes in the amounts of various chemicals (neurotransmitters, receptors, enzymes, and other metabolites) specific to the area of the central nervous system contained within the head. These are monitored over time, during sensory stimulation, or under different disease states. Chemistry, Brain,Brain Chemistries,Chemistries, Brain
D004743 Enkephalin, Leucine One of the endogenous pentapeptides with morphine-like activity. It differs from MET-ENKEPHALIN in the LEUCINE at position 5. Its first four amino acid sequence is identical to the tetrapeptide sequence at the N-terminal of BETA-ENDORPHIN. Leucine Enkephalin,5-Leucine Enkephalin,Leu(5)-Enkephalin,Leu-Enkephalin,5 Leucine Enkephalin,Enkephalin, 5-Leucine,Leu Enkephalin
D004744 Enkephalin, Methionine One of the endogenous pentapeptides with morphine-like activity. It differs from LEU-ENKEPHALIN by the amino acid METHIONINE in position 5. Its first four amino acid sequence is identical to the tetrapeptide sequence at the N-terminal of BETA-ENDORPHIN. Methionine Enkephalin,5-Methionine Enkephalin,Met(5)-Enkephalin,Met-Enkephalin,5 Methionine Enkephalin,Enkephalin, 5-Methionine,Met Enkephalin
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D014018 Tissue Distribution Accumulation of a drug or chemical substance in various organs (including those not relevant to its pharmacologic or therapeutic action). This distribution depends on the blood flow or perfusion rate of the organ, the ability of the drug to penetrate organ membranes, tissue specificity, protein binding. The distribution is usually expressed as tissue to plasma ratios. Distribution, Tissue,Distributions, Tissue,Tissue Distributions

Related Publications

H Taquet, and F Javoy-Agid, and M Hamon, and J C Legrand, and Y Agid, and F Cesselin
December 1999, Nihon rinsho. Japanese journal of clinical medicine,
H Taquet, and F Javoy-Agid, and M Hamon, and J C Legrand, and Y Agid, and F Cesselin
January 1980, Neuroscience letters,
H Taquet, and F Javoy-Agid, and M Hamon, and J C Legrand, and Y Agid, and F Cesselin
July 2010, Nihon rinsho. Japanese journal of clinical medicine,
H Taquet, and F Javoy-Agid, and M Hamon, and J C Legrand, and Y Agid, and F Cesselin
May 1983, European journal of pharmacology,
H Taquet, and F Javoy-Agid, and M Hamon, and J C Legrand, and Y Agid, and F Cesselin
January 1979, Clinical and experimental pharmacology & physiology,
H Taquet, and F Javoy-Agid, and M Hamon, and J C Legrand, and Y Agid, and F Cesselin
January 1982, Advances in biochemical psychopharmacology,
H Taquet, and F Javoy-Agid, and M Hamon, and J C Legrand, and Y Agid, and F Cesselin
May 1977, FEBS letters,
H Taquet, and F Javoy-Agid, and M Hamon, and J C Legrand, and Y Agid, and F Cesselin
October 1981, Neuroscience letters,
H Taquet, and F Javoy-Agid, and M Hamon, and J C Legrand, and Y Agid, and F Cesselin
January 1981, Neuroscience,
H Taquet, and F Javoy-Agid, and M Hamon, and J C Legrand, and Y Agid, and F Cesselin
December 1989, European journal of pharmacology,
Copied contents to your clipboard!